C3 and systemic lupus erythematosus: Roldan et al.'s study also noted that certain categories of SLE patients have an increased risk of developing LVDD, and this includes those with longer SLE duration, severe SLE (as determined either by SLEDAI or damage score), and higher levels of acute-phase reactants, such as C3 levels [43].